Detalhe da pesquisa
1.
The pharmacological chaperone N-butyldeoxynojirimycin enhances enzyme replacement therapy in Pompe disease fibroblasts.
Mol Ther;
17(6): 964-71, 2009 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19293774
2.
The novel ETS factor TEL2 cooperates with Myc in B lymphomagenesis.
Mol Cell Biol;
25(6): 2395-405, 2005 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15743832
3.
ETV7 is an essential component of a rapamycin-insensitive mTOR complex in cancer.
Sci Adv;
4(9): eaar3938, 2018 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30258985
4.
Satellite cells maintain regenerative capacity but fail to repair disease-associated muscle damage in mice with Pompe disease.
Acta Neuropathol Commun;
6(1): 119, 2018 11 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30404653
5.
High MN1 expression increases the in vitro clonogenic activity of primary mouse B-cells.
Leuk Res;
39(8): 906-12, 2015 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26111797
6.
Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease.
EMBO Mol Med;
5(5): 691-706, 2013 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23606558
7.
Abnormal mannose-6-phosphate receptor trafficking impairs recombinant alpha-glucosidase uptake in Pompe disease fibroblasts.
Pathogenetics;
1(1): 6, 2008 Dec 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19046416
8.
Prospects for gene therapy in inherited neurodegenerative diseases.
Curr Opin Neurol;
20(2): 151-8, 2007 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17351484
9.
Correction of Hunter syndrome in the MPSII mouse model by AAV2/8-mediated gene delivery.
Hum Mol Genet;
15(7): 1225-36, 2006 Apr 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16505002